Biologicals

Yellow Fever

WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines

Geneva, Switzerland, 13-14 May 2009

WHO Informal Consultation of the minimum potency specification for yellow fever vaccines

National Institute for Biological Standards & Control (NIBSC), Potters Bar, UK, 19-20 November 2007

IABS Scientific Workshop on Neurovirulence Tests for Live Virus Vaccines

WHO, Geneva, Switzerland, 31 January-1 February, 2005

UPCOMING EVENTS


  • WHO Informal Consultation on Regulatory considerations for evaluation of Ebola Vaccines intended for emergency use, WHO/HQ Geneva, Switzerland, 18-19 March 2015
  • WHO Informal Consultation on Stability Evaluation of Vaccines for use in a Controlled Temperature Chain, WHO/HQ Geneva, Switzerland, 24–26 March 2015
  • WHO Informal Consultation on Amendment for Similar Biotherapeutic products of monoclonal antibodies, WCC, Geneva, Switzerland, 27–28 April 2015
  • WHO Informal Consultation on Regulatory risk assessment for biotherapeutic products, WCC, Geneva, Switzerland, 29–30 April 2015

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971